Rapid Platform icIEF Methods Development with AESlyte HR 5–10.5 for Diverse mAbs
Spotlight | The AESlyte Rapid Method Development Kit is designed to streamline and accelerate the creation of icIEF methods for mAbs and various biotherapeutics.
Landing pages (23)
Landing pages (1080 x 1080 px)
New Landing pages (6)
Beyond GMP: Selecting and Managing CDMOs for Biological Products
30 September 2026 | Articulate why regulatory compliance is an entry criterion, not a differentiator, and identify the three failure modes that standard audits consistently miss for biological products.
Qualification of Host Cell Protein ELISA and Phase-specific HCP Strategy
28 October 2026 | With expert from Cygnus Technologies | Better understand the advantages and limitations of Host Cell Protein (HCP) ELISA.
Heading – Proxima Nova Black
Cygnus Technologies
Eric Bishop
Prospective ICH Q2(R2)-Aligned Total-Error Validation of Label-Free Untargeted Proteomics for Host Cell Protein Quantification in Biotherapeutics
Spotlight | A regulatory-oriented framework that enables advanced LC-MS/MS proteomics workflows to move closer to routine biopharmaceutical quality control.
Advertisement
Advertisement
Advertisement